Gifthealth Appoints Chip Parkinson as Chief Executive Officer to Accelerate Growth and Innovation in Pharmacy Services

Gifthealth, a technology-driven pharmacy care company dedicated to making prescription access easier and more affordable, is pleased to announce the appointment of Chip Parkinson as its new Chief Executive Officer.

Sapio Sciences Introduces Biorepository Management Solution in Sapio Release 25.4

Latest release of Sapio Platform streamlines sample workflows and delivers centralized, compliant biospecimen management

Ambience Healthcare Collaborates with Houston Methodist to Revolutionize Emergency and Inpatient Care

Vector Laboratories and Spatomics Present Novel Method for Multiplexed Spatial Profiling of Glycans and Proteins at AACR

Leader in manufacturing reagents and critical components for biomedical research partners with spatial biology solutions company to support simultaneous detection of 10+ markers in a single tissue sample using off-the-shelf antibodies and lectins

Verista Highlights COUNTQ® Tray Inspection Systems

The release highlights the COUNTQ® Tray Inspection System, an advanced AI-enabled inspection and reconciliation system designed to revolutionize the counting and verification of vials, syringes, ampoules, and other tray-loaded parts in pharmaceutical manufacturing.

Stellaromics Announces First Deployment of Pyxa Platform in Europe

Stellaromics, a pioneer in 3D spatial biology, announced its first European deployment of the Pyxa Platform through an early access partnership with Dr. Nigel Jamieson at the University of Glasgow. Dr. Jamieson’s team will use Pyxa’s 3D spatial multi-omics workflow to investigate tumor architecture and the surrounding microenvironment, work that could inform new biomarker discoveries and advance future cancer diagnostics and therapies.

EpiCypher Launches Novel, Affordable DNA Methylation Sequencing Assays to Accelerate Drug Discovery

EpiCypher® has announced the launch of CUTANA® meCUT&RUN and Multiomic CUT&RUN, two novel DNA methylation sequencing technologies advancing the frontiers of genomic research and drug discovery.

Press Release: Zymo Research Launches Green DNA/RNA Dry Transport System

The press release highlights key advantages of the Green DNA/RNA Dry Transport System: it eliminates the need for cold chain logistics (such as dry ice and Styrofoam), drastically reducing environmental impact and shipping costs, while maintaining the integrity of DNA and RNA samples at room temperature. This innovation is ideal for transporting sequencing-ready libraries for any commercial platform, making it especially valuable for researchers and professionals needing fast, reliable, and sustainable sample transport solutions.

Ambience Healthcare’s AI Platform for Documentation, CDI, and Coding Now Available in Microsoft Azure Marketplace

Dovetail Genomics Unveils Ultra-Sensitive Somatic Variant Detection and AI-Driven Analysis Ahead of AACR 2025

Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types

Biodesix, Inc (Nasdaq: BDSX), a leading diagnostics solutions company, and Bio-Rad Laboratories (NYSE: BIO), a global leader in life science research and diagnostics products, contributed to new research findings from Friends of Cancer Research’s (Friends’) ctMoniTR Project, recently published in Clinical Cancer Research (CCR).

BioSkryb Genomics and Ultima Genomics Launch Collaborative Grant Program to Advance Oncology Research

BioSkryb Genomics and Ultima Genomics have launched a joint grant program to accelerate oncology research by providing scientists with access to cutting-edge multi-omic and sequencing technologies. The collaboration pairs BioSkryb’s ultra–low-input single-cell and multi-omic platforms with Ultima’s scalable, cost-efficient sequencing, enabling researchers to explore complex cancer biology with high resolution and reduced cost barriers. The grant will award selected projects with comprehensive studies covering up to 2,000 single-cell genomes at no charge, prioritizing innovative work in somatic mosaicism, clonal heterogeneity, residual disease, and ultra–low-input samples. Applications are due June 20, 2025.

Two New Clinical Studies Demonstrate Accuracy of Viz.ai Algorithm for Intracranial Hemorrhage Volume Measurements to Advance Timely, Critical Treatment Decisions

Real-world evidence supports Viz ICH Plus for reliable volume and midline shift estimation.

Integrated DNA Technologies Introduces Transformative Hybridization Capture Solution to Accelerate Cancer Research

New xGen™ hybridization and wash offering is poised to revolutionize targeted next generation sequencing workflows

Symbiosis Earns Recognition from EcoVadis for Commitment to Sustainability

Symbiosis Pharmaceutical Services, a specialist sterile manufacturing CMO, who has been formally recognised by EcoVadis for its continued commitment to sustainability.

CluePoints’ Technology Named as Finalist in 2025 Citeline Awards

CluePoints, provider of leading statistical and AI-driven software solutions, has been named as a finalist in the ‘Innovative Clinical Trial Solutions’ category at the 2025 Citeline Awards.

VieCure Integrates NCCN Content into Leading Technology Platform for Community Oncology Care

VieCure is making thousands of the most commonly used NCCN Chemotherapy Order Templates available on its Halo Intelligence Platform.

Oxford Nanopore Expands Compatible Products Programme and Strengthens Multi-Omics Ecosystem

Oxford Nanopore Technologies announced the expansion of its Compatible Products Program. New participating companies include: 10x Genomics, Agilent Technologies, Asuragen, Day Zero Diagnostics, Hamilton Robotics, NEB, Opentrons, Pathosense, and Thermo Fisher Scientific.

Meribel Pharma Solutions launches with big ambitions to elevate pharma services to new heights

The launch of a new mid-sized CDMO, Meribel Pharma Solutions, bringing together 10 manufacturing sites and 3 development centres across Europe. The team – including ex-Synerlab and Catalent leadership – aims to offer agile, high-quality solutions across OSD, sterile, and semi-solid manufacturing. Built on a strong legacy, the company is filling a much-needed niche in the market with centres of excellence in lyophilisation, preservative-free multidose tech, and more.

Nuclera expands eProtein Discovery capabilities to enable membrane protein production

● Membrane proteins synthesized and purified within 48 hours. ● Active membrane transporter, MsbA and integral membrane protein, ZMPSTE24 synthesized